Next-gen cell therapy manufacturing: leveraging flexibility and automation for success
Year: 2025
Type: article
Abstract: Despite several cell therapy approvals, existing manufacturing capacity is inadequate to meet high patient demand. Automation is poised to play a crucial role in enhancing global patient access to these treatments. This article delves into the advanced technologies and automation strategies that are essential for navigating the evolving cell and gene therapy landscape, featuring insights from both the biopharma and tool provider sectors.
Source: Cell and Gene Therapy Insights
Authors: David Shaw, Fred Parietti, Carl Dargitz
Institutions: Genentech, Thermo Fisher Scientific (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7115166314
FWCI:
Cites:
Cited by:
Related to: